Patient questionnaires may add a new layer to chronic lymphocytic leukemia prognosis
A new study indicates that patient-reported outcomes from quality-of-life questionnaires can help predict survival and risk in chronic lymphocytic leukemia (CLL) patients. Researchers suggest that systematically tracking these symptoms provides a valuable, often overlooked, dimension to clinical prognosis.
Why it matters
Integrating patient-reported data into clinical practice could lead to more personalized treatment plans and better risk stratification for cancer patients.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Unsplash/CC0 Public Domain Patients' responses to questions routinely raised by oncologists may provide important clues about their chances of survival from chronic lymphocytic leukemia (CLL), according to a new study published in the journal Therapeutic Advances in Hematology .
The research suggests that carefully listening to patients and systematically evaluating what they say about their symptoms and daily functioning can help predict outcomes, improve prognosis and identify individuals at higher risk.
The study pooled individual patient data from 1,238 people with CLL enrolled in three major international randomized clinical trials and reanalyzed outcomes with ibrutinib-based treatment strategies.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in